NUWE | Nuwellis, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	1.2600 - 1.3434
52 Week Range	1.0000 - 30.10
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	56,236
Average Volume	2,831,971
Shares Outstanding	4,373,967
Market Cap	5,620,548
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2012-02-16

Valuation
Profitability
Growth
Health
P/E Ratio	-0.02
Forward P/E Ratio	-4.52
EPS	-60.77
1YR Price Target	20.50
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	59
Country	USA
Website	NUWE

Nuwellis Inc is a medical device company. Its solutions include Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flow, automatically displaying real-time data to the medical staff.

NUWE's peers: AEMD, BBLG, BJDX, BSGM, BVS, ECOR, HSDT, MYO, NAOV, NSPR, NURO, RSLS, TNON, RMED, INVO, THMO, SINT, TIVC, TLIS, HSCS, VERO, VVOS

*Chart delayed

Analyzing fundamentals for NUWE we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is frighteningly weak. For more detailed analysis please see NUWE Fundamentals page.

Watching at NUWE technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on NUWE Technicals page.